Senior Director, Rare Epilepsy HCP & Payer Marketing
LundbeckDeerfield, IL, United StatesSenior Director, Rare Epilepsy HCP & Payer Marketing.Bexicaserin is an investigational therapy that has not been approved by the Food and Drug Administration (FDA) for use in Developmental and Epil... Mostrar más